BluGlass Limited Expands Defence Collaboration Through New Development Program
BluGlass Limited (ASX: BLG) has secured a multi-phased development program valued at AU$1.25 million with a leading United States-based tier-1 defence and aerospace technology provider. The program follows successful prototype testing of the company’s gallium nitride (GaN) gain chips and includes an initial purchase order worth AU$560,000, which will be delivered over approximately seven to nine months.
Under the agreement, BluGlass will develop packaged visible GaN distributed feedback (DFB) lasers and gain chips designed to combine a laser and optical amplifier within a single integrated solution. These components are expected to support advanced defence and aerospace systems by delivering high power and precision at visible wavelengths while improving system efficiency and reducing integration complexity. The broader development program is anticipated to progress over fourteen to twenty months, with further phases dependent on achieving technical milestones. Successful execution could open opportunities for additional development projects and longer-term product revenue streams within the defence and aerospace sectors.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
BluGlass Limited Expands Defence Collaboration Through New Development Program
BluGlass Limited (ASX: BLG) has secured a multi-phased development program valued at AU$1.25 million with a leading United States-based tier-1 defence and aerospace technology provider. The program follows successful prototype testing of the company’s gallium nitride (GaN) gain chips and includes an initial purchase order worth AU$560,000, which will be delivered over approximately seven to nine months.
Under the agreement, BluGlass will develop packaged visible GaN distributed feedback (DFB) lasers and gain chips designed to combine a laser and optical amplifier within a single integrated solution. These components are expected to support advanced defence and aerospace systems by delivering high power and precision at visible wavelengths while improving system efficiency and reducing integration complexity. The broader development program is anticipated to progress over fourteen to twenty months, with further phases dependent on achieving technical milestones. Successful execution could open opportunities for additional development projects and longer-term product revenue streams within the defence and aerospace sectors.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au